Evidence map›Paper›PMID 35128541›Full record

ArticleSVOA neurology2021

Moderate Intensity Exercise in Pre-manifest Huntington's Disease: Results of a 6 months Trial.

Amro Saad Aldine, Amy Ogilvie, John Wemmie, James Kent, Jordan Schultz, Jeffrey D Long, John Kamholz, Hassan Sajjad, Joel Kline, Emily Shaw and 3 more

Abstract read
In one paragraph

Article in SVOA neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Amro Saad AldineDepartment of Radiology, Ochsner LSU Health Shreveport Academic Medical Center, Shreveport, LA, 71103, USA.
Amy OgilvieDepartment of Biostatistics, The University of Iowa, Iowa City, IA, 52240, USA.
John WemmieDepartment of Psychiatry, The University of Iowa, Iowa City, IA, 52240, USA.
James KentDepartment of Psychology, The University of Texas, Austin, Texas, 78712, USA.
Jordan SchultzDepartment of Psychiatry, The University of Iowa, Iowa City, IA, 52240, USA.
Jeffrey D LongDepartment of Biostatistics, The University of Iowa, Iowa City, IA, 52240, USA.
John KamholzDepartment of Neurology, The University of Iowa, Iowa City, IA, 52240, USA.
Hassan SajjadDepartment of Internal Medicine, The University of Iowa, Iowa City, IA, 52240, USA.
Joel KlineDepartment of Internal Medicine, The University of Iowa, Iowa City, IA, 52240, USA.
Emily ShawDepartment of Community and Behavioral Health, The University of Iowa, Iowa City, IA, 52240, USA.
Michelle VossDepartment of Psychological and Brain Sciences, The University of Iowa, Iowa City, IA, 52240, USA.
Jane S PaulsenDepartment of Neurology, The University of Wisconsin, Madison, WI, 53705, USA.
Vincent A MagnottaDepartment of Psychiatry, The University of Iowa, Iowa City, IA, 52240, USA.

Funding

NEUROBIOLOGICAL PREDICTORS OF HUNTINGTON'S DISEASER01NS040068 · NINDS · UNIVERSITY OF IOWA · PI PAULSEN, JANE S · 2001 to 2013
$48.5M
The University of Iowa Clinical and Translational Science AwardUL1TR002537 · NCATS · UNIVERSITY OF IOWA · PI HANSEN, MARLAN R, WINOKUR, PATRICIA · 2018 to 2022
$20.0M
Preparing for preventive clinical trials in Huntington's diseaseU01NS105509 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI PAULSEN, JANE S · 2020 to 2025
$2.5M
University of Iowa - Research 3T MRI Connectome UpgradeS10OD025025 · OD · UNIVERSITY OF IOWA · PI MAGNOTTA, VINCENT A · 2018 to 2018
$1.9M
Statistical disease modeling and clinimetrics to prepare for preventive trials in huntington diseaseU01NS103475 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI PAULSEN, JANE S · 2020 to 2022
$1.7M
Statistical disease modeling and clinimetrics to prepare for preventive trials in huntington diseaseR01NS103475 · NINDS · UNIVERSITY OF IOWA · PI PAULSEN, JANE S, ZHANG, YING · 2017 to 2018
$1.2M
Preparing for preventive clinical trials in Huntington's diseaseR01NS105509 · NINDS · UNIVERSITY OF IOWA · PI PAULSEN, JANE S · 2018 to 2018
$658k
Exercise Intervention for Slowing HD ProgressionR21NS091055 · NINDS · UNIVERSITY OF IOWA · PI MAGNOTTA, VINCENT A · 2015 to 2016
$418k
NCATS NIH HHS UL1 TR002537NIH HHS S10 OD025025NINDS NIH HHS R01 NS040068NINDS NIH HHS R01 NS103475NINDS NIH HHS R01 NS105509NINDS NIH HHS R21 NS091055NINDS NIH HHS U01 NS103475NINDS NIH HHS U01 NS105509
6 · The paper itself

Abstract

backgroundWhile it has been shown that aerobic exercise interventions are well tolerated in participants with the Huntington disease (HD) gene mutation, no study to date has tested whether an aerobic exercise intervention benefits brain structure and function in pre-manifest HD.

objectiveIn this study we utilized magnetic resonance (MR) imaging techniques to assess the efficacy of moderate-to-vigorous exercise treatment relative to active stretching and toning control.

methodsForty pre-manifest participants with confirmed HD gene expansion were recruited into a two-arm intervention study that included a moderate-to-vigorous intensity home-based walking exercise intervention (N=34) and an active stretching and toning control intervention (N=6). Participants were assessed at baseline and after 26 weeks in one of the two study arms.

results25 of the 34 (74%) participants assigned to the moderate-to-vigorous intensity group completed the intervention while 4 of the 6 (67%) participants in the stretching and toning intervention completed the study. The primary analyses compared the two arms of the study and found no statistical differences between the groups. Both groups were found to have improved their cardiorespiratory fitness as assessed by maximal oxygen uptake (VO

conclusionsThough this study did not show efficacy for the exercise intervention, secondary results suggest that aerobic exercise interventions increasing cardiorespiratory fitness may be a potential way to slow progression in pre-manifest HD.

Indexed as

Huntington (Disease)Moderate exercise IntensityMRINeuroimagingpre-manifest disease

Identifiers

PMID35128541
PMCPMC8815110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.